Search bioRxiv⌕ Search

bioRxiv · 10.1101/2022.12.25.521906

The forward variable selection based optimized decoding toolbox for neuroimaging data

Abstract

Neuroimaging data is complex and high-dimensional that poses challenges for machine learning (ML) applications. Of varieties of reasons contributing on accuracy decoding, variable feature selection is one of crucial steps for determining target feature in data analysis, especially in the context of neuroimaging studies where the number of features is often much larger than the number of observations. Therefore, optimization of feature selection from such high-dimensional neuroimaging data has been challenging using conventional ML algorithms. Here, we introduce an efficient ML package incorporating a forward variable selection (FVS) algorithm that optimizes the identification of features for both classification and regression models. In our framework, the best ML model and feature pairs that explain the inputs can be automatically determined. Moreover, the toolbox can be executed in a parallel environment for efficient computation. The parallelized FVS algorithm iteratively selects the best feature pair compared against the previous steps to maximize the predictive performance. The FVS algorithm evaluates the goodness-of-fit across different models using the k-fold cross validation and identifies the best subset of features based on a pre-defined criterion for each model. Furthermore, the hyperparameters of each ML model are optimized at each forward iteration. A final outcome highlights an optimized number of selected features (brain regions of interest) with decoding accuracies. Using our pipeline, we examined the effectiveness of our toolbox on an existing neuroimaging (structural MRI) dataset. Compared ML models with and without FVS approach, we demonstrate that the FVS significantly improved the accuracy of the ML algorithm over the counterpart model without FVS. Furthermore, we confirmed the use of parallel computation considerably reduced the computational burden for the high-dimensional MRI data. This oFVSD toolbox efficiently and effectively improves the performance of both classification and regression models on neuroimaging data and should be applicable to many other neuroimaging data and more. This Python package is open-source and freely available, making it a useful toolbox for neuroimaging communities seeking improvement of decoding accuracy for their datasets.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Dang, T., Fermin, A. S. R., Machizawa, M. G.. 2022-12-25. The forward variable selection based optimized decoding toolbox for neuroimaging data. https://doi.org/10.1101/2022.12.25.521906

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience↗

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience↗

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience↗